286 related articles for article (PubMed ID: 34561552)
1. Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases.
Ou AT; Zhang JX; Fang YF; Wang R; Tang XP; Zhao PF; Zhao YG; Zhang M; Huang YZ
Acta Pharmacol Sin; 2021 Nov; 42(11):1913-1920. PubMed ID: 34561552
[TBL] [Abstract][Full Text] [Related]
2. The anti-alcoholism drug disulfiram effectively ameliorates ulcerative colitis through suppressing oxidative stresses-associated pyroptotic cell death and cellular inflammation in colonic cells.
Chi F; Zhang G; Ren N; Zhang J; Du F; Zheng X; Zhang C; Lin Z; Li R; Shi X; Zhu Y
Int Immunopharmacol; 2022 Oct; 111():109117. PubMed ID: 35969897
[TBL] [Abstract][Full Text] [Related]
3. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation.
Hu JJ; Liu X; Xia S; Zhang Z; Zhang Y; Zhao J; Ruan J; Luo X; Lou X; Bai Y; Wang J; Hollingsworth LR; Magupalli VG; Zhao L; Luo HR; Kim J; Lieberman J; Wu H
Nat Immunol; 2020 Jul; 21(7):736-745. PubMed ID: 32367036
[TBL] [Abstract][Full Text] [Related]
4. Repurposing Disulfiram to Combat Acute Respiratory Distress Syndrome with Targeted Delivery by LET-Functionalized Nanoplatforms.
Tian Y; Chen L; He M; Du H; Qiu X; Lai X; Bao S; Jiang W; Ren J; Zhang A
ACS Appl Mater Interfaces; 2024 Mar; 16(10):12244-12262. PubMed ID: 38421312
[TBL] [Abstract][Full Text] [Related]
5. Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.
Song W; Tang Z; Lei T; Wen X; Wang G; Zhang D; Deng M; Tang X; Chen X
Nanomedicine; 2016 Feb; 12(2):377-86. PubMed ID: 26711966
[TBL] [Abstract][Full Text] [Related]
6. Disulfiram Improves Fat Graft Retention by Modulating Macrophage Polarization With Inhibition of NLRP3 Inflammasome-Mediated Pyroptosis.
Chen X; Chen W; Xu H; Tian Y; Wang X; Chen X; Li J; Luo S; Hao L
Aesthet Surg J; 2024 Jun; 44(7):NP501-NP518. PubMed ID: 38567442
[TBL] [Abstract][Full Text] [Related]
7. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment.
Luo R; Lin M; Fu C; Zhang J; Chen Q; Zhang C; Shi J; Pu X; Dong L; Xu H; Ye N; Sun J; Lin D; Deng B; McDowell A; Fu S; Gao F
Carbohydr Polym; 2021 Jul; 263():117998. PubMed ID: 33858583
[TBL] [Abstract][Full Text] [Related]
8. Disulfiram blocks inflammatory TLR4 signaling by targeting MD-2.
Bai Y; Min R; Chen P; Mei S; Deng F; Zheng Z; Jiang C; Miao R; Wu Z; Zhang P; Pan Y; Lieberman J; Liu X
Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2306399120. PubMed ID: 37487070
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram-loaded mixed nanoparticles with high drug-loading and plasma stability by reducing the core crystallinity for intravenous delivery.
Zhuo X; Lei T; Miao L; Chu W; Li X; Luo L; Gou J; Zhang Y; Yin T; He H; Tang X
J Colloid Interface Sci; 2018 Nov; 529():34-43. PubMed ID: 29883928
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis.
Zhuang L; Luo X; Wu S; Lin Z; Zhang Y; Zhai Z; Yang F; Li Y; Zhuang J; Luo G; Xu W; He Y; Sun E
Cell Death Discov; 2022 Sep; 8(1):379. PubMed ID: 36057687
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-modified lactoferrin nanoparticles coated with a laminarin layer loaded curcumin with dual-targeting for ulcerative colitis treatment.
Ye N; Zhao P; Ayue S; Qi S; Ye Y; He H; Dai L; Luo R; Chang D; Gao F
Int J Biol Macromol; 2023 Mar; 232():123229. PubMed ID: 36642354
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of ulcerative colitis
Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.
Hamblin KA; Flick-Smith H; Barnes KB; Pereira-Leal JB; Surkont J; Hampson R; Atkins HS; Harding SV
Int J Antimicrob Agents; 2019 Jul; 54(1):85-88. PubMed ID: 31029736
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative and apoptosis-triggering potential of disulfiram and disulfiram-loaded polysorbate 80-stabilized PLGA nanoparticles on hepatocellular carcinoma Hep3B cell line.
Hoda M; Pajaniradje S; Shakya G; Mohankumar K; Rajagopalan R
Nanomedicine; 2016 Aug; 12(6):1641-50. PubMed ID: 27013133
[TBL] [Abstract][Full Text] [Related]
15. Honokiol alleviates ulcerative colitis by targeting PPAR-γ-TLR4-NF-κB signaling and suppressing gasdermin-D-mediated pyroptosis in vivo and in vitro.
Wang N; Kong R; Han W; Bao W; Shi Y; Ye L; Lu J
Int Immunopharmacol; 2022 Oct; 111():109058. PubMed ID: 35901530
[TBL] [Abstract][Full Text] [Related]
16. Modulating synovial macrophage pyroptosis and mitophagy interactions to mitigate osteoarthritis progression using functionalized nanoparticles.
Qi W; Jin L; Huang S; Aikebaier A; Xue S; Wang Q; Chen Q; Lu Y; Ding C
Acta Biomater; 2024 Jun; 181():425-439. PubMed ID: 38729544
[TBL] [Abstract][Full Text] [Related]
17. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats.
El-Fakharany EM; El-Gendi H; El-Maradny YA; Abu-Serie MM; Abdel-Wahhab KG; Shabana ME; Ashry M
Int J Biol Macromol; 2023 Aug; 245():125552. PubMed ID: 37356684
[TBL] [Abstract][Full Text] [Related]
19. Disulfiram attenuates lipopolysaccharide-induced acute kidney injury by suppressing oxidative stress and NLRP3 inflammasome activation in mice.
Huang J; Wei S; Peng Z; Xiao Z; Yang Y; Liu J; Zhang B; Li W
J Pharm Pharmacol; 2022 Feb; 74(2):259-267. PubMed ID: 34923585
[TBL] [Abstract][Full Text] [Related]
20. Control of systemic inflammation through early nitric oxide supplementation with nitric oxide releasing nanoparticles.
Williams AT; Muller CR; Govender K; Navati MS; Friedman AJ; Friedman JM; Cabrales P
Free Radic Biol Med; 2020 Dec; 161():15-22. PubMed ID: 33011274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
